We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNFP icon
901
Pinnacle Financial Partners Inc
PNFP
$16.2B
$41.5M 0.01%
764,087
-1,300
-0.2% -$64.4K
INVN
902
DELISTED
Invensense Inc
INVN
$41.3M 0.01%
2,737,740
+4,900
+0.2% +$74K
MMS icon
903
Maximus
MMS
$2.94B
$41.3M 0.01%
628,800
+32,600
+5% +$2.13M
CHSP
904
DELISTED
Chesapeake Lodging Trust
CHSP
$41.3M 0.01%
1,354,620
-3,800
-0.3% -$120K
ASEI
905
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
$41.2M 0.01%
939,723
-191,660
-17% -$8.29M
NPKI
906
NPK International
NPKI
$1.18B
$41.2M 0.01%
5,062,230
+5,022,730
+12,716% +$46.5M
BFH icon
907
Bread Financial
BFH
$4.51B
$40.9M 0.01%
175,385
+10,771
+7% +$2.58M
TPH
908
DELISTED
Tri Pointe Homes
TPH
$40.8M 0.01%
2,667,913
+66,940
+3% +$995K
WELL icon
909
Welltower
WELL
$169B
$40.6M 0.01%
618,110
+19,970
+3% +$1.43M
HMIN
910
DELISTED
HOMEINNS HOTEL GROUP SPONSORED ADR
HMIN
$40.5M 0.01%
1,310,061
+387,142
+42% +$10.8M
SNA icon
911
Snap-on
SNA
$20.9B
$40.3M 0.01%
252,977
+80,581
+47% +$12.4M
PFBC icon
912
Preferred Bank
PFBC
$1.28B
$40.1M 0.01%
1,332,986
+3,006
+0.2% +$85.9K
HAYN
913
DELISTED
Haynes International, Inc.
HAYN
$40M 0.01%
810,548
-1,600
-0.2% -$74.8K
TR icon
914
Tootsie Roll Industries
TR
$3.02B
$39.9M 0.01%
1,710,620
+296,416
+21% +$6.86M
SNDA icon
915
Sonida Senior Living
SNDA
$1.88B
$39.8M 0.01%
108,381
-7,912
-7% -$3.06M
CEB
916
DELISTED
CEB Inc.
CEB
$39.6M 0.01%
454,700
-2,600
-0.6% -$221K
ELRC
917
DELISTED
ELECTRO RENT CORP
ELRC
$39.3M 0.01%
3,621,650
-213,130
-6% -$2.32M
VGR
918
DELISTED
Vector Group Ltd.
VGR
$39.3M 0.01%
3,013,232
+213,103
+8% +$2.65M
LLTC
919
DELISTED
Linear Technology Corp
LLTC
$39.3M 0.01%
887,490
+11,800
+1% +$549K
EQY
920
DELISTED
Equity One
EQY
$39.1M 0.01%
1,674,696
-5,800
-0.3% -$145K
MCRB icon
921
Seres Therapeutics
MCRB
$45M
$39M 0.01%
+48,054
New +$41.9M
CNS icon
922
Cohen & Steers
CNS
$4.4B
$38.8M 0.01%
1,137,990
-3,500
-0.3% -$132K
HMSY
923
DELISTED
HMS Holdings Corp.
HMSY
$38.8M 0.01%
2,257,778
-4,100
-0.2% -$69.3K
GDOT icon
924
Green Dot
GDOT
$770M
$38.4M 0.01%
2,010,645
-6,163
-0.3% -$100K
UBNK
925
DELISTED
United Financial Bancorp, Inc.
UBNK
$38.4M 0.01%
2,856,157
+687,680
+32% +$8.88M

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.